Pathogenetix
Latest round
- Series C
Last raised
- Oct 2013
Total raised
- $47M
Investors
- 7
About Pathogenetix
Founded in 1997 and headquartered in Woburn, US, Pathogenetix focuses on genomic analysis for pathogen identification.00 mn, with its most recent deal occurring on February 13, 2015.Pathogenetix specializes in advanced genomic analysis solutions, primarily focusing on rapid and accurate pathogen identification. Their core product offerings include a sophisticated platform that utilizes proprietary technology for sequencing and analyzing microbial DNA, instrumental in applications like food safety, clinical diagnostics, and environmental monitoring.Pathogenetix generates revenue through B2B partnerships and direct sales to institutional clients, including hospitals, laboratories, and food safety authorities. Revenue streams primarily stem from the sale of its genomic analysis platform and associated services such as support and maintenance, typically following a subscription model or one-time licensing agreements.Pathogenetix plans to expand its portfolio with new product launches expected to enhance pathogen detection capabilities. The company is targeting expansion into the European and Asian markets by the end of 2016.00 mn will support these initiatives, particularly in technological advancements and market penetration strategies. In February 2015, Pathogenetix’s Pathogen ID Technology was acquired by Toxic Reports, indicating a strategic shift and potential new directions for the company.
Who invested in Pathogenetix
7 investors across 4 rounds
See all investors in Pathogenetix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pathogenetix
Who invested in Pathogenetix?
Pathogenetix has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pathogenetix raised?
Pathogenetix has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Pathogenetix last raise money?
Pathogenetix's most recent round on record is a Series C, in Oct 2013.
What does Pathogenetix do?
Founded in 1997 and headquartered in Woburn, US, Pathogenetix focuses on genomic analysis for pathogen identification.
Where is Pathogenetix headquartered?
Pathogenetix is headquartered in Woburn, US.
Which VCs invest in companies like Pathogenetix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pathogenetix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Pathogenetix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.